China National Medicines Corporation Ltd. provided earnings guidance for the first half of 2017. The company predicts that the net profit belonging to shareholders of the company in the first half of 2017 will be between RMB 511,046,000 and RMB 569,451,300, with an increase between 75% and 95% compared with the same period of the year before and a predicted increase of between 8% and 20% in purchased assets in reorganization compared with the same period of the year before.